These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 8868142

  • 21. Procoagulant albumin increases vascular endothelial cell prostacyclin secretion.
    Gubler DB, Ahlstrom CR, Liu L, Zhou JF, Parker CJ, Rodgers GM.
    Thromb Haemost; 1995 Dec; 74(6):1573-7. PubMed ID: 8772239
    [Abstract] [Full Text] [Related]

  • 22. Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.
    Ueshima S, Matsuno H, Hayashi M, Horibuchi K, Okada K, Fukao H, Uematsu T, Matsuo O.
    Thromb Haemost; 2002 Jun; 87(6):1069-74. PubMed ID: 12083488
    [Abstract] [Full Text] [Related]

  • 23. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.
    Lijnen HR, Wagner EF, Collen D.
    Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597
    [Abstract] [Full Text] [Related]

  • 24. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
    Lijnen HR, Silence J, Lemmens G, Frederix L, Collen D.
    Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
    [Abstract] [Full Text] [Related]

  • 25. Biology of the endothelium.
    Lüscher TF, Barton M.
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-3-10. PubMed ID: 9422846
    [Abstract] [Full Text] [Related]

  • 26. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW, Helmy A, Ludlam C, Webb DJ, Hayes PC, Newby DC.
    Thromb Res; 2008 Nov; 121(5):675-80. PubMed ID: 17870147
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of vascular endothelial cell prostacyclin synthesis by plasmin.
    Schafer AI, Rodriguez R, Loscalzo J, Gimbrone MA.
    Blood; 1989 Aug 15; 74(3):1015-20. PubMed ID: 2526669
    [Abstract] [Full Text] [Related]

  • 28. Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans.
    Gudmundsdóttir IJ, Lang NN, Boon NA, Ludlam CA, Webb DJ, Fox KA, Newby DE.
    J Am Coll Cardiol; 2008 May 06; 51(18):1749-56. PubMed ID: 18452780
    [Abstract] [Full Text] [Related]

  • 29. Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium.
    Mitchell JA, Ali F, Bailey L, Moreno L, Harrington LS.
    Exp Physiol; 2008 Jan 06; 93(1):141-7. PubMed ID: 17965142
    [Abstract] [Full Text] [Related]

  • 30. Coagulation and endothelial dysfunction during longterm hyperdynamic porcine bacteremia--effects of selective inducible nitric oxide synthase inhibition.
    Matejovic M, Krouzecky A, Radej J, Rokyta R, Kralova H, Radermacher P, Novak I.
    Thromb Haemost; 2007 Feb 06; 97(2):304-9. PubMed ID: 17264961
    [Abstract] [Full Text] [Related]

  • 31. Platelets and endothelial cells act in concert to delay thrombolysis--evidence from an in vitro model of the human occlusive thrombus.
    Hantgan RR, Jerome WG, Handt S.
    Thromb Haemost; 1998 Mar 06; 79(3):602-8. PubMed ID: 9531049
    [Abstract] [Full Text] [Related]

  • 32. Secretion of tissue plasminogen activator and plasminogen activator inhibitor 1 during cardiopulmonary bypass.
    Chandler WL, Velan T.
    Thromb Res; 2003 Mar 06; 112(3):185-92. PubMed ID: 14967416
    [Abstract] [Full Text] [Related]

  • 33. Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase.
    Schaefer U, Vorlova S, Machida T, Melchor JP, Strickland S, Levi R.
    J Pharmacol Exp Ther; 2007 Jul 06; 322(1):265-73. PubMed ID: 17429057
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
    Cruden NL, Tse GH, Fox KA, Ludlam CA, Megson I, Newby DE.
    Arterioscler Thromb Vasc Biol; 2005 Apr 06; 25(4):772-7. PubMed ID: 15681300
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Secretory function of vascular endothelium and its implication in the action of vasoactive drugs.
    Gryglewski RJ.
    Pol J Pharmacol Pharm; 1990 Apr 06; 42(3):219-36. PubMed ID: 2263533
    [Abstract] [Full Text] [Related]

  • 38. Prostacyclin in hypertension.
    Frölich JC.
    J Hypertens Suppl; 1990 Sep 06; 8(4):S73-8. PubMed ID: 2258788
    [Abstract] [Full Text] [Related]

  • 39. A paradox of thrombogenesis by streptokinase and its prevention by iloprost and camonagrel.
    Korbut R, Gryglewski RJ.
    Methods Find Exp Clin Pharmacol; 1996 Apr 06; 18(3):167-74. PubMed ID: 8738067
    [Abstract] [Full Text] [Related]

  • 40. Platelet-vessel wall interactions, focal adhesions, and the mechanism of action of endothelial factors.
    Walter U, Geiger J, Haffner C, Markert T, Nehls C, Silber RE, Schanzenbächer P.
    Agents Actions Suppl; 1995 Apr 06; 45():255-68. PubMed ID: 7717187
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.